Monitoring and Assessment of Neuropsychological Outcomes as a Standard of Care in Pediatric Oncology

Pediatric Blood and Cancer

Volumn 62, Issue , 2015, Pages S460-S513

  Annett, Robert D ^a   Patel, Sunita K ^b   Phipps, Sean ^c  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Children; Neuropsychology; Outcomes

Indexed keywords

ARTICLE; ATTENTION; BRAIN TUMOR; CANCER SURVIVOR; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; COGNITION; COGNITION ASSESSMENT; COGNITIVE DEFECT; EXECUTIVE FUNCTION; HEALTH CARE QUALITY; HIGH RISK PATIENT; HUMAN; INTELLIGENCE; LANGUAGE; MEDICAL LITERATURE; MEMORY; NEUROLOGIC DISEASE; NEUROPSYCHOLOGICAL TEST; PATIENT MONITORING; PERCEPTION; PRIORITY JOURNAL; SENSATION; SYSTEMATIC REVIEW; WORKING MEMORY; ADVERSE EFFECTS; CENTRAL NERVOUS SYSTEM; COMPLICATION; DRUG EFFECTS; PRACTICE GUIDELINE; RADIATION RESPONSE; RADIOTHERAPY; STANDARDS;

ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM; HUMANS; NEUROPSYCHOLOGICAL TESTS; PRACTICE GUIDELINES AS TOPIC; RADIOTHERAPY; STANDARD OF CARE;

EID: 84952662429     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25749     Document Type: Article

References (150)

1. American Academy of Pediatrics Section on Hematology/Oncology Children's Oncology G. Long-term follow-up care for pediatric cancer survivors. Pediatrics 2009; 123:906-915.
2. Armstrong GT. Long-term survivors of childhood central nervous system malignancies: The experience of the Childhood cancer survivor study. Eur J Paediatr Neurol 2010; 14:298-303.
3. Collie A, Maruff P, Darby DG, McStephen M. The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test-retest intervals. J Int Neuropsychol Soc 2003; 9:419-428.
4. Embry L, Annett RD, Kunin-Batson A, Patel SK, Sands S, Reaman G, Noll RB. Implementation of multi-site neurocognitive assessments within a pediatric cooperative group: Can it be done? Pediatr Blood Cancer 2012; 59:536-539.
5. Gershon RC, Cella D, Fox NA, Havlik RJ, Hendrie HC, Wagster MV. Assessment of neurological and behavioural function: The NIH toolbox. Lancet Neurol 2010; 9:138-139.
6. Krull KR, Okcu MF, Potter B, Jain N, Dreyer Z, Kamdar K, Brouwers P. Screening for neurocognitive impairment in pediatric cancer long-term survivors. J Clin Oncol 2008; 26:4138-4143.
7. Anderson FS, Kunin-Batson AS, Perkins JL, Scott Baker K. White versus gray matter function as seen on neuropsychological testing following bone marrow transplant for acute leukemia in childhood. Neuropsychiatr Dis Treat 2008; 4:283-288.
8. Mulhern RK, Palmer SL, Reddick WE, Glass JO, Kun LE, Taylor J, Langston J, Gajjar A. Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. J Clin Oncol 2001; 19:472-479.
9. Palmer SL, Reddick WE, Glass JO, Ogg R, Patay Z, Wallace D, Gajjar A. Regional white matter anisotropy and reading ability in patients treated for pediatric embryonal tumors. Brain Imaging Behav 2010; 4:132-140.
10. Wiener L, Kazak AE, Noll RB, Patenaude AF, MJ K. Standards for psychosocial care of children with cancer and their families: An introduction to the special issue. Pediatr Blood Cancer 2015; 62 (Suppl 5):419-424.
11. Annett RD, Hile S, Bedrick E, Kunin-Batson AS, Krull KR, Embry L, MacLean WE, Jr., Noll RB. Neuropsychological functioning of children treated for acute lymphoblastic leukemia: Impact of whole brain radiation therapy. Psychooncology 2015; 24:181-189.
12. Copeland DR, Moore BD, Francis DJ, Jaffe N, Culbert SJ. Neuropsychologic effects of chemotherapy on children with cancer: A longitudinal study. J Clin Oncol 1996; 14:2826-2835.
13. Di Pinto M, Conklin HM, Li C, Merchant TE. Learning and memory following conformal radiation therapy for pediatric craniopharyngioma and low-grade glioma. Int J Radiat Oncol Biol Phys 2012; 84:e363-e369.
14. Jalali R, Mallick I, Dutta D, Goswami S, Gupta T, Munshi A, Deshpande D, Sarin R. Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy. Int J Radiat Oncol Biol Phys 2010; 77:974-979.
15. Kramer JH, Crittenden MR, DeSantes K, Cowan MJ. Cognitive and adaptive behavior 1 and 3 years following bone marrow transplantation. Bone Marrow Transplant 1997; 19:607-613.
16. Kupst MJ, Penati B, Debban B, Camitta B, Pietryga D, Margolis D, Murray K, Casper J. Cognitive and psychosocial functioning of pediatric hematopoietic stem cell transplant patients: A prospective longitudinal study. Bone Marrow Transplant 2002; 30:609-617.
17. Mabbott DJ, Monsalves E, Spiegler BJ, Bartels U, Janzen L, Guger S, Laperriere N, Andrews N, Bouffet E. Longitudinal evaluation of neurocognitive function after treatment for central nervous system germ cell tumors in childhood. Cancer 2011; 117:5402-5411.
18. Merchant TE, Conklin HM, Wu S, Lustig RH, Xiong X. Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: Prospective evaluation of cognitive, endocrine, and hearing deficits. J Clin Oncol 2009; 27:3691-3697.
19. Montour-Proulx I, Kuehn SM, Keene DL, Barrowman NJ, Hsu E, Matzinger MA, Dunlap H, Halton JM. Cognitive changes in children treated for acute lymphoblastic leukemia with chemotherapy only according to the Pediatric oncology group 9605 protocol. J Child Neurol 2005; 20:129-133.
20. Netson KL, Conklin HM, Ashford JM, Kahalley LS, Wu S, Xiong X. Parent and teacher ratings of attention during a year-long methylphenidate trial in children treated for cancer. J Pediatr Psychol 2011; 36:438-450.
21. Netson KL, Conklin HM, Wu S, Xiong X, Merchant TE. A 5-year investigation of children's adaptive functioning following conformal radiation therapy for localized ependymoma. Int J Radiat Oncol Biol Phys 2012; 84:217-223e211.
22. Netson KL, Conklin HM, Wu S, Xiong X, Merchant TE. Longitudinal investigation of adaptive functioning following conformal irradiation for pediatric craniopharyngioma and low-grade glioma. Int J Radiat Oncol Biol Phys 2013; 85:1301-1306.
23. Palmer SL, Goloubeva O, Reddick WE, Glass JO, Gajjar A, Kun L, Merchant TE, Mulhern RK. Patterns of intellectual development among survivors of pediatric medulloblastoma: A longitudinal analysis. J Clin Oncol 2001; 19:2302-2308.
24. Palmer SL, Hassall T, Evankovich K, Mabbott DJ, Bonner M, Deluca C, Cohn R, Fisher MJ, Morris EB, Broniscer A, Gajjar A. Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma. Neuro Oncol 2010; 12:1311-1317.
25. Palmer SL, Armstrong C, Onar-Thomas A, Wu S, Wallace D, Bonner MJ, Schreiber J, Swain M, Chapieski L, Mabbott D, Knight S, Boyle R, Gajjar A. Processing speed, attention, and working memory after treatment for medulloblastoma: An international, prospective, and longitudinal study. J Clin Oncol 2013; 31:3494-3500.
26. Phipps S, Dunavant M, Srivastava DK, Bowman L, Mulhern RK. Cognitive and academic functioning in survivors of pediatric bone marrow transplantation. J Clin Oncol 2000; 18:1004-1011.
27. Phipps S, Rai SN, Leung WH, Lensing S, Dunavant M. Cognitive and academic consequences of stem-cell transplantation in children. J Clin Oncol 2008; 26:2027-2033.
28. Simms S, Kazak AE, Golomb V, Goldwein J, Bunin N. Cognitive, behavioral, and social outcome in survivors of childhood stem cell transplantation. J Pediatr Hematol Oncol 2002; 24:115-119.
29. Shah AJ, Epport K, Azen C, Killen R, Wilson K, De Clerck D, Crooks G, Kapoor N, Kohn DB, Parkman R, Weinberg KI. Progressive declines in neurocognitive function among survivors of hematopoietic stem cell transplantation for pediatric hematologic malignancies. J Pediatr Hematol Oncol 2008; 30:411-418.
30. Willard VW, Leung W, Huang Q, Zhang H, Phipps S. Cognitive outcome after pediatric stem-cell transplantation: Impact of age and total-body irradiation. J Clin Oncol 2014; 32:3982-3988.
31. Cheung YT, Krull KR. Neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: A systematic review. Neurosci Biobehav Rev 2015; 53:108-120.
32. de Ruiter MA, van Mourik R, Schouten-van Meeteren AY, Grootenhuis MA, Oosterlaan J. Neurocognitive consequences of a paediatric brain tumour and its treatment: A meta-analysis. Dev Med Child Neurol 2013; 55:408-417.
33. Iyer NS, Balsamo LM, Bracken MB, Kadan-Lottick NS. Chemotherapy-only treatment effects on long-term neurocognitive functioning in childhood ALL survivors: A review and meta-analysis. Blood 2015; 126:346-353.
34. Peterson CC, Johnson CE, Ramirez LY, Huestis S, Pai AL, Demaree HA, Drotar D. A meta-analysis of the neuropsychological sequelae of chemotherapy-only treatment for pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer 2008; 51:99-104.
35. Smithson EF, Phillips R, Harvey DW, Morrall MC. The use of stimulant medication to improve neurocognitive and learning outcomes in children diagnosed with brain tumours: A systematic review. Eur J Cancer 2013; 49:3029-3040.
36. Robinson KE, Kuttesch JF, Champion JE, Andreotti CF, Hipp DW, Bettis A, Barnwell A, Compas BE. A quantitative meta-analysis of neurocognitive sequelae in survivors of pediatric brain tumors. Pediatr Blood Cancer 2010; 55:525-531.
37. Armstrong GT, Conklin HM, Huang S, Srivastava D, Sanford R, Ellison DW, Merchant TE, Hudson MM, Hoehn ME, Robison LL, Gajjar A, Morris EB. Survival and long-term health and cognitive outcomes after low-grade glioma. Neuro Oncol 2011; 13:223-234.
38. Chiou SS, Jang RC, Liao YM, Yang P. Health-related quality of life and cognitive outcomes among child and adolescent survivors of leukemia. Support Care Cancer 2010; 18:1581-1587.
39. Conklin HM, Krull KR, Reddick WE, Pei D, Cheng C, Pui CH. Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia. J Natl Cancer Inst 2012; 104:1386-1395.
40. De Smet HJ, Baillieux H, Wackenier P, De Praeter M, Engelborghs S, Paquier PF, De Deyn PP, Marien P. Long-term cognitive deficits following posterior fossa tumor resection: A neuropsychological and functional neuroimaging follow-up study. Neuropsychology 2009; 23:694-704.
41. Davis EE, Pitchford NJ, Jaspan T, McArthur D, Walker D. Development of cognitive and motor function following cerebellar tumour injury sustained in early childhood. Cortex 2010; 46:919-932.
42. Finkelstein-Shechter T, Gassas A, Mabbott D, Huang A, Bartels U, Tabori U, Janzen L, Hawkins C, Taylor M, Bouffet E. Atypical teratoid or rhabdoid tumors: Improved outcome with high-dose chemotherapy. J Pediatr Hematol Oncol 2010; 32:e182-e186.
43. Hardy KK, Bonner MJ, Willard VW, Watral MA, Gururangan S. Hydrocephalus as a possible additional contributor to cognitive outcome in survivors of pediatric medulloblastoma. Psychooncology 2008; 17:1157-1161.
44. Harila MJ, Winqvist S, Lanning M, Bloigu R, Harila-Saari AH. Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2009; 53:156-161.
45. Hilverda K, Bosma I, Heimans JJ, Postma TJ, Peter Vandertop W, Slotman BJ, Buter J, Reijneveld JC, Klein M. Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: Initial findings. J Neurooncol 2010; 97:89-94.
46. Jarvela LS, Hurme S, Holopainen IE, Leino M, Hatanpaa AM, Mikola H, Karki T, Salmi TT, Lahteenmaki PM. Auditory event related potentials as tools to reveal cognitive late effects in childhood cancer patients. Clin Neurophysiol 2011; 122:62-72.
47. Kadan-Lottick NS, Brouwers P, Breiger D, Kaleita T, Dziura J, Liu H, Chen L, Nicoletti M, Stork L, Bostrom B, Neglia JP. A comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood acute lymphoblastic leukemia. Blood 2009; 114:1746-1752.
48. Kadan-Lottick NS, Brouwers P, Breiger D, Kaleita T, Dziura J, Northrup V, Chen L, Nicoletti M, Bostrom B, Stork L, Neglia JP. Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia. J Clin Oncol 2009; 27:5986-5992.
49. Kesler SR, Tanaka H, Koovakkattu D. Cognitive reserve and brain volumes in pediatric acute lymphoblastic leukemia. Brain Imaging Behav 2010; 4:256-269.
50. Krull KR, Minoshima S, Edelmann M, Morris B, Sabin ND, Brinkman TM, Armstrong GT, Robison LL, Hudson MM, Shulkin B. Regional brain glucose metabolism and neurocognitive function in adult survivors of childhood cancer treated with cranial radiation. J Nucl Med 2014; 55:1805-1810.
51. Kupeli S, Yalcin B, Bilginer B, Akalan N, Haksal P, Buyukpamukcu M. Posterior fossa syndrome after posterior fossa surgery in children with brain tumors. Pediatr Blood Cancer 2011; 56:206-210.
52. Kunin-Batson A, Kadan-Lottick N, Neglia JP. The contribution of neurocognitive functioning to quality of life after childhood acute lymphoblastic leukemia. Psychooncology 2014; 23:692-699.
53. Larysz D, Blamek S, Larysz P, Pietras K, Mandera M. Posterior fossa brain tissue injury: Developmental, neuropsychological, and neurological consequences of brain tumors in children. Acta Neurochir Suppl 2010; 106:271-274.
54. Mahone EM, Prahme MC, Ruble K, Mostofsky SH, Schwartz CL. Motor and perceptual timing deficits among survivors of childhood leukemia. J Pediatr Psychol 2007; 32:918-925.
55. Merchant TE, Schreiber JE, Wu S, Lukose R, Xiong X, Gajjar A. Critical combinations of radiation dose and volume predict intelligence quotient and academic achievement scores after craniospinal irradiation in children with medulloblastoma. Int J Radiat Oncol Biol Phys 2014; 90:554-561.
56. Merchant TE, Sharma S, Xiong X, Wu S, Conklin H. Effect of cerebellum radiation dosimetry on cognitive outcomes in children with infratentorial ependymoma. Int J Radiat Oncol Biol Phys 2014; 90:547-553.
57. Moxon-Emre I, Bouffet E, Taylor MD, Laperriere N, Scantlebury N, Law N, Spiegler BJ, Malkin D, Janzen L, Mabbott D. Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastoma. J Clin Oncol 2014; 32:1760-1768.
58. Patel SK, Mullins WA, O'Neil SH, Wilson K. Neuropsychological differences between survivors of supratentorial and infratentorial brain tumours. J Intellect Disabil Res 2011; 55:30-40.
59. Protas PT, Muszynska-Roslan K, Holownia A, Grabowska A, Krawczuk-Rybak M, Braszko JJ. Cerebrospinal fluid changes in the excitatory amino acids concentration caused by the standard treatment of acute lymphoblastic leukaemia in children do not correlate with their later cognitive functioning. Neuropediatrics 2009; 40:295-297.
60. Protas PT, Muszynska-Roslan K, Holownia A, Grabowska A, Wielgat P, Krawczuk-Rybak M, Braszko JJ. Negative correlation between cerebrospinal fluid tau protein and cognitive functioning in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2009; 53:105-108.
61. Puget S, Boddaert N, Viguier D, Kieffer V, Bulteau C, Garnett M, Callu D, Sainte-Rose C, Kalifa C, Dellatolas G, Grill J. Injuries to inferior vermis and dentate nuclei predict poor neurological and neuropsychological outcome in children with malignant posterior fossa tumors. Cancer 2009; 115:1338-1347.
62. Reddick WE, Taghipour DJ, Glass JO, Ashford J, Xiong X, Wu S, Bonner M, Khan RB, Conklin HM. Prognostic factors that increase the risk for reduced white matter volumes and deficits in attention and learning for survivors of childhood cancers. Pediatr Blood Cancer 2014; 61:1074-1079.
63. Reimers TS, Mortensen EL, Nysom K, Schmiegelow K. Health-related quality of life in long-term survivors of childhood brain tumors. Pediatr Blood Cancer 2009; 53:1086-1091.
64. Robinson KE, Pearson MM, Cannistraci CJ, Anderson AA, Kuttesch JF, Wymer K, Smith SE, Compas BE. Neuroimaging of executive function in survivors of pediatric brain tumors and healthy controls. Neuropsychology 2014; 28:791-800.
65. Rueckriegel SM, Blankenburg F, Henze G, Baque H, Driever PH. Loss of fine motor function correlates with ataxia and decline of cognition in cerebellar tumor survivors. Pediatr Blood Cancer 2009; 53:424-431.
66. Sands SA, Oberg JA, Gardner SL, Whiteley JA, Glade-Bender JL, Finlay JL. Neuropsychological functioning of children treated with intensive chemotherapy followed by myeloablative consolidation chemotherapy and autologous hematopoietic cell rescue for newly diagnosed CNS tumors: An analysis of the Head Start II survivors. Pediatr Blood Cancer 2010; 54:429-436.
67. Spiegler BJ, Bouffet E, Greenberg ML, Rutka JT, Mabbott DJ. Change in neurocognitive functioning after treatment with cranial radiation in childhood. J Clin Oncol 2004; 22:706-713.
68. Schreiber JE, Gurney JG, Palmer SL, Bass JK, Wang M, Chen S, Zhang H, Swain M, Chapieski ML, Bonner MJ, Mabbott DJ, Knight SJ, Armstrong CL, Boyle R, Gajjar A. Examination of risk factors for intellectual and academic outcomes following treatment for pediatric medulloblastoma. Neuro Oncol 2014; 16:1129-1136.
69. Schubert T, Trippel M, Tacke U, van Velthoven V, Gumpp V, Bartelt S, Ostertag C, Nikkhah G. Neurosurgical treatment strategies in childhood craniopharyngiomas: Is less more? Childs Nerv Syst 2009; 25:1419-1427.
70. Schulte F, Bartels U, Bouffet E, Janzen L, Hamilton J, Barrera M. Body weight, social competence, and cognitive functioning in survivors of childhood brain tumors. Pediatr Blood Cancer 2010; 55:532-539.
71. Shortman RI, Lowis SP, Penn A, McCarter RJ, Hunt LP, Brown CC, Stevens MC, Curran AL, Sharples PM. Cognitive function in children with brain tumors in the first year after diagnosis compared to healthy matched controls. Pediatr Blood Cancer 2014; 61:464-472.
72. Turner CD, Chordas CA, Liptak CC, Rey-Casserly C, Delaney BL, Ullrich NJ, Goumnerova LC, Scott RM, Begley HC, Fletcher WJ, Yao X, Chi S, Kieran MW. Medical, psychological, cognitive and educational late-effects in pediatric low-grade glioma survivors treated with surgery only. Pediatr Blood Cancer 2009; 53:417-423.
73. Wells EM, Khademian ZP, Walsh KS, Vezina G, Sposto R, Keating RF, Packer RJ. Postoperative cerebellar mutism syndrome following treatment of medulloblastoma: Neuroradiographic features and origin. J Neurosurg Pediatr 2010; 5:329-334.
74. Aarsen FK, Paquier PF, Arts WF, Van Veelen ML, Michiels E, Lequin M, Catsman-Berrevoets CE. Cognitive deficits and predictors 3 years after diagnosis of a pilocytic astrocytoma in childhood. J Clin Oncol 2009; 27:3526-3532.
75. Anderson VA, Godber T, Smibert E, Weiskop S, Ekert H. Impairments of attention following treatment with cranial irradiation and chemotherapy in children. J Clin Exp Neuropsychol 2004; 26:684-697.
76. Horska A, Laclair A, Mohamed M, Wells CT, McNutt T, Cohen KJ, Wharam M, Mahone EM, Kates W. Low cerebellar vermis volumes and impaired neuropsychologic performance in children treated for brain tumors and leukemia. AJNR Am J Neuroradiol 2010; 31:1430-1437.
77. Jain N, Brouwers P, Okcu MF, Cirino PT, Krull KR. Sex-specific attention problems in long-term survivors of pediatric acute lymphoblastic leukemia. Cancer 2009; 115:4238-4245.
78. Kahalley LS, Conklin HM, Tyc VL, Hudson MM, Wilson SJ, Wu S, Xiong X, Hinds PS. Slower processing speed after treatment for pediatric brain tumor and acute lymphoblastic leukemia. Psychooncology 2013; 22:1979-1986.
79. Krull KR, Bhojwani D, Conklin HM, Pei D, Cheng C, Reddick WE, Sandlund JT, Pui CH. Genetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia. J Clin Oncol 2013; 31:2182-2188.
80. Lai JS, Zelko F, Butt Z, Cella D, Kieran MW, Krull KR, Magasi S, Goldman S. Parent-perceived child cognitive function: Results from a sample drawn from the US general population. Childs Nerv Syst 2011; 27:285-293.
81. Mabbott DJ, Snyder JJ, Penkman L, Witol A. The effects of treatment for posterior fossa brain tumors on selective attention. J Int Neuropsychol Soc 2009; 15:205-216.
82. Robinson KE, Livesay KL, Campbell LK, Scaduto M, Cannistraci CJ, Anderson AW, Whitlock JA, Compas BE. Working memory in survivors of childhood acute lymphocytic leukemia: Functional neuroimaging analyses. Pediatr Blood Cancer 2010; 54:585-590.
83. Callu D, Viguier D, Laroussinie F, Puget S, Boddaert N, Kieffer V, Piana H, Escolano S, Renier D, Sainte-Rose C, Grill J, Dellatolas G. Cognitive and academic outcome after benign or malignant cerebellar tumor in children. Cogn Behav Neurol 2009; 22:270-278.
84. Conklin HM, Ashford JM, Di Pinto M, Vaughan CG, Gioia GA, Merchant TE, Ogg RJ, Santana V, Wu S. Computerized assessment of cognitive late effects among adolescent brain tumor survivors. J Neurooncol 2013; 113:333-340.
85. Di Pinto M, Conklin HM, Li C, Xiong X, Merchant TE. Investigating verbal and visual auditory learning after conformal radiation therapy for childhood ependymoma. Int J Radiat Oncol Biol Phys 2010; 77:1002-1008.
86. Di Rocco C, Chieffo D, Pettorini BL, Massimi L, Caldarelli M, Tamburrini G. Preoperative and postoperative neurological, neuropsychological and behavioral impairment in children with posterior cranial fossa astrocytomas and medulloblastomas: The role of the tumor and the impact of the surgical treatment. Childs Nerv Syst 2010; 26:1173-1188.
87. Edelmann MN, Krull KR, Liu W, Glass JO, Ji Q, Ogg RJ, Sabin ND, Srivastava DK, Robison LL, Hudson MM, Reddick WE. Diffusion tensor imaging and neurocognition in survivors of childhood acute lymphoblastic leukaemia. Brain 2014; 137:2973-2983.
88. Kadan-Lottick NS, Zeltzer LK, Liu Q, Yasui Y, Ellenberg L, Gioia G, Robison LL, Krull KR. Neurocognitive functioning in adult survivors of childhood non-central nervous system cancers. J Natl Cancer Inst 2010; 102:881-893.
89. Ozyurt J, Thiel CM, Lorenzen A, Gebhardt U, Calaminus G, Warmuth-Metz M, Muller HL. Neuropsychological outcome in patients with childhood craniopharyngioma and hypothalamic involvement. J Pediatr 2014; 164:876-881e874.
90. Riggs L, Bouffet E, Laughlin S, Laperriere N, Liu F, Skocic J, Scantlebury N, Wang F, Schoenhoff NJ, Strother D, Hukin J, Fryer C, McConnell D, Mabbott DJ. Changes to memory structures in children treated for posterior fossa tumors. J Int Neuropsychol Soc 2014; 20:168-180.
91. Catsman-Berrevoets CE, Aarsen FK. The spectrum of neurobehavioural deficits in the Posterior Fossa Syndrome in children after cerebellar tumour surgery. Cortex 2010; 46:933-946.
92. Ashford J, Schoffstall C, Reddick WE, Leone C, Laningham FH, Glass JO, Pei D, Cheng C, Pui CH, Conklin HM. Attention and working memory abilities in children treated for acute lymphoblastic leukemia. Cancer 2010; 116:4638-4645.
93. Caron JE, Krull KR, Hockenberry M, Jain N, Kaemingk K, Moore IM. Oxidative stress and executive function in children receiving chemotherapy for acute lymphoblastic leukemia. Pediatr Blood Cancer 2009; 53:551-556.
94. Conklin HM, Ashford JM, Howarth RA, Merchant TE, Ogg RJ, Santana VM, Reddick WE, Wu S, Xiong X. Working memory performance among childhood brain tumor survivors. J Int Neuropsychol Soc 2012; 18:996-1005.
95. Howarth RA, Adamson AM, Ashford JM, Merchant TE, Ogg RJ, Schulenberg SE, Ogg S, Li J, Wu S, Xiong X, Conklin HM. Investigating the relationship between COMt polymorphisms and working memory performance among childhood brain tumor survivors. Pediatr Blood Cancer 2014; 61:40-45.
96. Howarth RA, Ashford JM, Merchant TE, Ogg RJ, Santana V, Wu S, Xiong X, Conklin HM. The utility of parent report in the assessment of working memory among childhood brain tumor survivors. J Int Neuropsychol Soc 2013; 19:380-389.
97. Jacola LM, Ashford JM, Reddick WE, Glass JO, Ogg RJ, Merchant TE, Conklin HM. The relationship between working memory and cerebral white matter volume in survivors of childhood brain tumors treated with conformal radiation therapy. J Neurooncol 2014; 119:197-205.
98. Kesler SR, Lacayo NJ, Jo B. A pilot study of an online cognitive rehabilitation program for executive function skills in children with cancer-related brain injury. Brain Inj 2011; 25:101-112.
99. Knight SJ, Conklin HM, Palmer SL, Schreiber JE, Armstrong CL, Wallace D, Bonner M, Swain MA, Evankovich KD, Mabbott DJ, Boyle R, Huang Q, Zhang H, Anderson VA, Gajjar A. Working memory abilities among children treated for medulloblastoma: Parent report and child performance. J Pediatr Psychol 2014; 39:501-511.
100. Law N, Bouffet E, Laughlin S, Laperriere N, Briere ME, Strother D, McConnell D, Hukin J, Fryer C, Rockel C, Dickson J, Mabbott D. Cerebello-thalamo-cerebral connections in pediatric brain tumor patients: Impact on working memory. Neuroimage 2011; 56:2238-2248.
101. Walsh KS, Paltin I, Gioia GA, Isquith P, Kadan-Lottick NS, Neglia JP, Brouwers P. Everyday executive function in standard-risk acute lymphoblastic leukemia survivors. Child Neuropsychol 2015; 21:78-89.
102. Winter AL, Conklin HM, Tyc VL, Stancel H, Hinds PS, Hudson MM, Kahalley LS. Executive function late effects in survivors of pediatric brain tumors and acute lymphoblastic leukemia. J Clin Exp Neuropsychol 2014; 36:818-830.
103. Wolfe KR, Walsh KS, Reynolds NC, Mitchell F, Reddy AT, Paltin I, Madan-Swain A. Executive functions and social skills in survivors of pediatric brain tumor. Child Neuropsychol 2013; 19:370-384.
104. Turner CD, Rey-Casserly C, Liptak CC, Chordas C. Late effects of therapy for pediatric brain tumor survivors. J Child Neurol 2009; 24:1455-1463.
105. Buizer AI, De Sonneville LM, van den Heuvel-Eibrink MM, Njiokiktjien C, Veerman AJ. Visuomotor control in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. J Int Neuropsychol Soc 2005; 11:554-565.
106. Conklin HM, Khan RB, Reddick WE, Helton S, Brown R, Howard SC, Bonner M, Christensen R, Wu S, Xiong X, Mulhern RK. Acute neurocognitive response to methylphenidate among survivors of childhood cancer: A randomized, double-blind, cross-over trial. J Pediatr Psychol 2007; 32:1127-1139.
107. Droit-Volet S, Zelanti PS, Dellatolas G, Kieffer V, El Massioui N, Brown BL, Doyere V, Provasi J, Grill J. Time perception in children treated for a cerebellar medulloblastoma. Res Dev Disabil 2013; 34:480-494.
108. Luxton J, Brinkman TM, Kimberg C, Robison LL, Hudson MM, Krull KR. Utility of the N-back task in survivors of childhood acute lymphoblastic leukemia. J Clin Exp Neuropsychol 2014; 36:944-955.
109. Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 2004; 5:399-408.
110. Edelstein K, Spiegler BJ, Fung S, Panzarella T, Mabbott DJ, Jewitt N, D'Agostino NM, Mason WP, Bouffet E, Tabori U, Laperriere N, Hodgson DC. Early aging in adult survivors of childhood medulloblastoma: Long-term neurocognitive, functional, and physical outcomes. Neuro Oncol 2011; 13:536-545.
111. Buizer AI, de Sonneville LM, van den Heuvel-Eibrink MM, Veerman AJ. Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: Effect of treatment intensity. Pediatr Blood Cancer 2005; 45:281-290.
112. Campbell LK, Scaduto M, Sharp W, Dufton L, Van Slyke D, Whitlock JA, Compas B. A meta-analysis of the neurocognitive sequelae of treatment for childhood acute lymphocytic leukemia. Pediatr Blood Cancer 2007; 49:65-73.
113. Spiegler BJ, Kennedy K, Maze R, Greenberg ML, Weitzman S, Hitzler JK, Nathan PC. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate. J Clin Oncol 2006; 24:3858-3864.
114. Arvidson J, Kihlgren M, Hall C, Lonnerholm G. Neuropsychological functioning after treatment for hematological malignancies in childhood, including autologous bone marrow transplantation. Pediatr Hematol Oncol 1999; 16:9-21.
115. Barrera M, Atenafu E. Cognitive, educational, psychosocial adjustment and quality of life of children who survive hematopoietic SCT and their siblings. Bone Marrow Transplant 2008; 42:15-21.
116. Cool VA. Long-term neuropsychological risks in pediatric bone marrow transplant: What do we know? Bone Marrow Transplant 1996; 18:S45-S49.
117. Hiniker SM, Agarwal R, Modlin LA, Gray CC, Harris JP, Million L, Kiamanesh EF, Donaldson SS. Survival and neurocognitive outcomes after cranial or craniospinal irradiation plus total-body irradiation before stem cell transplantation in pediatric leukemia patients with central nervous system involvement. Int J Radiat Oncol Biol Phys 2014; 89:67-74.
118. Notteghem P, Soler C, Dellatolas G, Kieffer-Renaux V, Valteau-Couanet D, Raimondo G, Hartmann O. Neuropsychological outcome in long-term survivors of a childhood extracranial solid tumor who have undergone autologous bone marrow transplantation. Bone Marrow Transplant 2003; 31:599-606.
119. Perkins JL, Kunin-Batson AS, Youngren NM, Ness KK, Ulrich KJ, Hansen MJ, Petryk A, Steinberger J, Anderson FS, Baker KS. Long-term follow-up of children who underwent hematopoeitic cell transplant (HCT) for AML or ALL at less than 3 years of age. Pediatr Blood Cancer 2007; 49:958-963.
120. Smedler AC, Winiarski J. Neuropsychological outcome in very young hematopoietic SCT recipients in relation to pretransplant conditioning. Bone Marrow Transplant 2008; 42:515-522.
121. Beebe DW, Ris MD, Armstrong FD, Fontanesi J, Mulhern R, Holmes E, Wisoff JH. Cognitive and adaptive outcome in low-grade pediatric cerebellar astrocytomas: Evidence of diminished cognitive and adaptive functioning in National Collaborative Research Studies (CCG 9891 /POG 9130). J Clin Oncol 2005; 23:5198-5204.
122. Ellenberg L, Liu Q, Gioia G, Yasui Y, Packer RJ, Mertens A, Donaldson SS, Stovall M, Kadan-Lottick N, Armstrong G, Robison LL, Zeltzer LK. Neurocognitive status in long-term survivors of childhood CNS malignancies: A report from the Childhood Cancer Survivor Study. Neuropsychology 2009; 23:705-717.
123. Mulhern RK, Palmer SL, Merchant TE, Wallace D, Kocak M, Brouwers P, Krull K, Chintagumpala M, Stargatt R, Ashley DM, Tyc VL, Kun L, Boyett J, Gajjar A. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol 2005; 23:5511-5519.
124. Qaddoumi I, Ellison DW, Morris EB, Broniscer A, Boop F, Merchant T, Palmer SL, Gajjar A. Dysembryoplastic neuroepithelial tumors and cognitive outcome: Cure at a price? Cancer 2010; 116:5461-5469.
125. Butler RW, Copeland DR, Fairclough DL, Mulhern RK, Katz ER, Kazak AE, Noll RB, Patel SK, Sahler OJ. A multicenter, randomized clinical trial of a cognitive remediation program for childhood survivors of a pediatric malignancy. J Consult Clin Psychol 2008; 76:367-378.
126. Askins MA, Moore BD, III. Preventing neurocognitive late effects in childhood cancer survivors. J Child Neurol 2008; 23:1160-1171.
127. Butler RW, Sahler OJ, Askins MA, Alderfer MA, Katz ER, Phipps S, Noll RB. Interventions to improve neuropsychological functioning in childhood cancer survivors. Dev Disabil Res Rev 2008; 14:251-258.
128. Butler RW, Copeland DR, Fairclough DL, Mulhern RK, Katz ER, Kazak AE, Noll RB, Patel SK, Sahler OJZ. A multicenter, randomized clinical trial of a cognitive remediation program for childhood survivors of a pediatric malignancy. J Consult Clin Psychol 2008; 76:367-378.
129. Hardy KK, Willard VW, Allen TM, Bonner MJ. Working memory training in survivors of pediatric cancer: a randomized pilot study. Psychooncology 2013; 22:1856-1865.
130. Hardy KK, Willard VW, Allen TM, Bonner MJ. Computerized cognitive training in survivors of childhood cancer: A pilot study. J Pediatr Oncol Nurs 2013; 28:27-33.
131. Moore IM, Hockenberry MJ, Anhalt C, McCarthy K, Krull KR. Mathematics intervention for prevention of neurocognitive deficits in childhood leukemia. Pediatr Blood Cancer 2012; 59:278-284.
132. Patel SK, Katz ER, Richardson R, Rimmer M, Kilian S. Cognitive and problem solving training in children with cancer: A pilot project. J Pediatr Hematol Oncol 2009; 31:670-677.
133. Sahler OJZ, Varni JW, Fairclough DL, Butler RW, Noll RB, Dolgin MJ, Phipps S, Copeland DR, Katz ER, Mulhern RK. Problem-solving skills training for mothers of children with newly diagnosed cancer: A randomized trial. J Dev Behav Pediatr 2002; 23:77-86.
134. Sahler OJZ, Fairclough DL, Phipps S, Mulhern RK, Dolgin MJ, Noll RB, Katz ER, Varni JW, Copeland DR, Butler RW. Using problem-solving skills training to reduce negative affectivity in mothers of children with newly diagnosed cancer: Report of a multisite randomized trial. J Consult Clin Psychol 2005; 73:272-283.
135. Sahler OJZ, Fairclough DL, Katz ER, Varni JW, Phipps S, Mulhern RK, Butler RW, Noll RB, Dolgin MJ, Copeland DR, Johnson WL, editors. Problem-solving skills training for mothers of children with newly diagnosed cancern. New York, NY: Oxford University Press; 2006. xv p. 586.
136. Zou P, Li Y, Conklin HM, Mulhern RK, Butler RW, Ogg RJ. Evidence of change in brain activity among childhood cancer survivors participating in a cognitive remediation program. Arch Clin Neuropsychol 2012; 27:915-929.
137. Patel SK, Ross P, Cuevas M, Turk A, Kim H, Lo TT, Wong LF, Bhatia S. Parent-directed intervention for children with cancer-related neurobehavioral late effects: A randomized pilot study. J Pediatr Psychol 2014; 39:1013-1027.
138. Castellino SM, Tooze JA, Flowers L, Hill DF, McMullen KP, Shaw EG, Parsons SK. Toxicity and efficacy of the acetylcholinesterase (AChe) inhibitor donepezil in childhood brain tumor survivors: A pilot study. Pediatr Blood Cancer 2012; 59:540-547.
139. Conklin HM, Lawford J, Jasper BW, Morris EB, Howard SC, Ogg SW, Wu S, Xiong X, Khan RB. Side effects of methylphenidate in childhood cancer survivors: A randomized placebo-controlled trial. Pediatrics 2009; 124:226-233.
140. Conklin HM, Helton S, Ashford J, Mulhern RK, Reddick WE, Brown R, Bonner M, Jasper BW, Wu S, Xiong X, Khan RB. Predicting methylphenidate response in long-term survivors of childhood cancer: A randomized, double-blind, placebo-controlled, crossover trial. J Pediatr Psychol 2010; 35:144-155.
141. Conklin HM, Reddick WE, Ashford J, Ogg S, Howard SC, Morris EB, Brown R, Bonner M, Christensen R, Wu S, Xiong X, Khan RB. Long-term efficacy of methylphenidate in enhancing attention regulation, social skills, and academic abilities of childhood cancer survivors. J Clin Oncol 2010; 28:4465-4472.
142. Mulhern RK, Khan RB, Kaplan S, Helton S, Christensen R, Bonner M, Brown R, Xiong X, Wu S, Gururangan S, Reddick WE. Short-term efficacy of methylphenidate: A randomized, double-blind, placebo-controlled trial among survivors of childhood cancer. J Clin Oncol 2004; 22:4795-4803.
143. Thompson SJ, Leigh L, Christensen R, Xiong X, Kun LE, Heideman RL, Reddick WE, Gajjar A, Merchant T, Pui CH, Hudson MM, Mulhern RK. Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. J Clin Oncol 2001; 19:1802-1808.
144. Council on children with D, section on developmental behavioral P, bright futures steering C, medical home initiatives for children with special needs project advisory C. Identifying infants and young children with developmental disorders in the medical home: An algorithm for developmental surveillance and screening. Pediatrics 2006; 118:405-420.
145. Quigg TC, Mahajerin A, Sullivan PD, Pradhan K, Bauer NS. Ages and Stages Questionnaires-3 developmental screening of infants and young children with cancer. J Pediatr Oncol Nurs 2013; 30:235-241.
146. Limbos MM, Joyce DP. Comparison of the ASQ and PEDS in screening for developmental delay in children presenting for primary care. J Dev Behav Pediatr 2011; 32:499-511.
147. Sices L, Stancin T, Kirchner L, Bauchner H. PEDS and ASQ developmental screening tests may not identify the same children. Pediatrics 2009; 124:e640-e647.
148. Roberts RM, Robins T, Gannoni AF, Tapp H. Survivors of childhood cancer in South Australia attending a late-effects clinic: A descriptive report of psychological, cognitive, and academic late-effects. J Psychosoc Oncol 2014; 32:152-166.
149. Verrill JR, Schafer J, Vannatta K, Noll RB. Aggression, antisocial behavior, and substance abuse in survivors of pediatric cancer: Possible protective effects of cancer and its treatment. J Pediatr Psychol 2000; 25:493-502.
150. Wolfe-Christensen C, Mullins LL, Stinnett TA, Carpentier MY, Fedele DA. Use of the behavioral assessment system for children 2nd edition: Parent report scale in pediatric cancer populations. J Clin Psychol Med Settings 2009; 16:322-330.